Amperos Health builds an AI-native platform that automates end-to-end denial management and revenue recovery for healthcare providers, using state-of-the-art large language models across voice, portal interactions, and document workflows. The company pairs agentic AI automation with a team of subject-matter experts to handle complex, difficult-to-recover claims and to deliver insights for optimizing billing and collections processes. Amperos is fully HIPAA-compliant and cites bank-level security for its product. Operating metrics disclosed include serving over 3,000 clinical locations across all 50 states and recovering nearly $700 million in revenue per year across more than 500,000 claims. Customer outcomes cited include recovering 22% more per claim at up to 50% lower cost (per investor commentary) and a customer report of recovering 24% more claims without increasing headcount. The company plans to use the Series A proceeds to accelerate growth, expand analytics, and launch agentic capabilities into additional RCM workflows. Prior to this round, Amperos raised a $4.2 million seed in June 2025.

Total raised

$20M

Funding rounds

2

Latest round

Series A

Latest activity

Apr 2026